CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,341,294 | -14.1% | 113,418 | -4.9% | 0.01% | -16.7% |
| Q2 2023 | $3,888,565 | +2.0% | 119,208 | +28.2% | 0.01% | 0.0% |
| Q1 2023 | $3,813,820 | -13.5% | 93,020 | -3.3% | 0.01% | -14.3% |
| Q4 2022 | $4,408,205 | -7.4% | 96,207 | -1.1% | 0.01% | -12.5% |
| Q3 2022 | $4,761,000 | +10.5% | 97,300 | +10.1% | 0.01% | +14.3% |
| Q2 2022 | $4,308,000 | +32.1% | 88,383 | -0.2% | 0.01% | +75.0% |
| Q1 2022 | $3,261,000 | -5.6% | 88,599 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,453,000 | +14.2% | 88,597 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $3,024,000 | +97.9% | 89,222 | +15.6% | 0.00% | +100.0% |
| Q2 2021 | $1,528,000 | -18.7% | 77,198 | -4.5% | 0.00% | -33.3% |
| Q1 2021 | $1,880,000 | +12.6% | 80,815 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $1,669,000 | -42.3% | 80,365 | -39.8% | 0.00% | -40.0% |
| Q3 2020 | $2,892,000 | +31.9% | 133,605 | +43.7% | 0.01% | +25.0% |
| Q2 2020 | $2,192,000 | +105.2% | 92,995 | +2.7% | 0.00% | +100.0% |
| Q1 2020 | $1,068,000 | +10.0% | 90,580 | -1.0% | 0.00% | +100.0% |
| Q4 2019 | $971,000 | -6.5% | 91,540 | +0.3% | 0.00% | -50.0% |
| Q3 2019 | $1,039,000 | +0.4% | 91,290 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $1,035,000 | +51.3% | 91,970 | +8.8% | 0.00% | +100.0% |
| Q1 2019 | $684,000 | +26.9% | 84,510 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $539,000 | -36.7% | 85,250 | -1.4% | 0.00% | 0.0% |
| Q3 2018 | $851,000 | +23.0% | 86,420 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $692,000 | +17.9% | 83,320 | +2.1% | 0.00% | 0.0% |
| Q1 2018 | $587,000 | -10.8% | 81,570 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $658,000 | -44.3% | 80,690 | -1.1% | 0.00% | -50.0% |
| Q3 2017 | $1,182,000 | +29.5% | 81,550 | +8.1% | 0.00% | +100.0% |
| Q2 2017 | $913,000 | +73.2% | 75,435 | +35.9% | 0.00% | 0.0% |
| Q2 2016 | $527,000 | -62.0% | 55,500 | -71.8% | 0.00% | -50.0% |
| Q1 2016 | $1,386,000 | -48.7% | 196,662 | -23.8% | 0.00% | -60.0% |
| Q4 2015 | $2,701,000 | +166.9% | 258,200 | +70.8% | 0.01% | +150.0% |
| Q3 2015 | $1,012,000 | +684.5% | 151,200 | +1011.8% | 0.00% | – |
| Q1 2014 | $129,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |